WashU Medicine Pathology & Immunology (@washu_pathology) 's Twitter Profile
WashU Medicine Pathology & Immunology

@washu_pathology

Department of Pathology & Immunology at WashU Medicine

ID: 1259861652167680002

linkhttp://www.pathology.wustl.edu calendar_today11-05-2020 15:03:34

1,1K Tweet

3,3K Followers

2,2K Following

Missouri Society of Pathologists (@mo_pathologists) 's Twitter Profile Photo

Two Weeks to the MSP 2024 Annual Meeting! The program committee has posted this year's program, "Current Updates in Pathology." Please check the website for the most up-to-date information. wjweis.association-service.org/securesite/msp…

WashU Medicine Pathology & Immunology (@washu_pathology) 's Twitter Profile Photo

We’re at the Missouri Dermatological Society 2024 Annual Meeting! Our own Dr. Aaron Russell is giving two talks. Be sure to stop by our table and say hello!

We’re at the Missouri Dermatological Society 2024 Annual Meeting! Our own Dr. Aaron Russell is giving two talks. Be sure to stop by our table and say hello!
Jonathan Kipnis 💔🎗️ (@jonykipnis) 's Twitter Profile Photo

Finished the first day of #ReThinkNeuroimmunology What an amazing collection of unpublished stories through lectures and posters. And what an amazing audience! Tomorrow will be even more amazing, starting the morning with the one and only NedergaardLab 🤩

WashU Medicine Pathology & Immunology (@washu_pathology) 's Twitter Profile Photo

Ali Ellebedy, PhD, Professor in the Dept. of Pathology & Immunology, is leading a newly funded study to identify the factors that are responsible for long-lasting immunity against disease. Read more here: pathology.wustl.edu/news/

Ali Ellebedy, PhD, Professor in the Dept. of Pathology & Immunology, is leading a newly funded study to identify the factors that are responsible for long-lasting immunity against disease. Read more here: pathology.wustl.edu/news/
Bernd H Zinselmeyer (@zinselmeyerb) 's Twitter Profile Photo

#rethinkneuroimmunology brainimmunologygliacenter.wustl.edu/items/2024-ret… Fantastic and inspiring talk from @GwenRandolph_ – highlighting our collaboration on developing new #imaging #tools @WUSTL WashU Medicine WashU Medicine Pathology & Immunology Education WashU Medicine Pathology & Immunology

#rethinkneuroimmunology 

brainimmunologygliacenter.wustl.edu/items/2024-ret…

Fantastic and inspiring talk from @GwenRandolph_  – highlighting our collaboration on developing new #imaging #tools 

@WUSTL 
<a href="/washumedicine/">WashU Medicine</a>
<a href="/washupathedu/">WashU Medicine Pathology & Immunology Education</a>
<a href="/washu_pathology/">WashU Medicine Pathology & Immunology</a>
WashU Medicine Pathology & Immunology Education (@washupathedu) 's Twitter Profile Photo

We're excited to share that the Pathology Residency Program at WashU Medicine will be releasing invites for interviews in the afternoon on October 16, 2024. We look forward to meeting with many of you!

WashU Medicine Pathology & Immunology (@washu_pathology) 's Twitter Profile Photo

The Department of Pathology and Immunology is proud to announce that two of our faculty members have played significant roles in the groundbreaking research that contributed to this year’s Nobel Prize recipients in Physiology or Medicine and Chemistry. tinyurl.com/4v3ed7db

The Department of Pathology and Immunology is proud to announce that two of our faculty members have played significant roles in the groundbreaking research that contributed to this year’s Nobel Prize recipients in Physiology or Medicine and Chemistry.

tinyurl.com/4v3ed7db
Fouad Boulos (@fouad_boulos) 's Twitter Profile Photo

Attendance is limited for this interactive microscopy session but it would be great to see familiar faces and names if you happen to be attending CAPathologists 2024 annual meeting 10/18-10/22 in Las Vegas! events.cap.org/event/e0103151…

WashU Medicine Pathology & Immunology (@washu_pathology) 's Twitter Profile Photo

GatewaySeq is a tumor-only, targeted next-gen sequencing assay developed by WashU Medicine pathologists. It offers a genomic assessment of solid tumors at initial diagnosis, relapse, and/or metastasis.

GatewaySeq is a tumor-only, targeted next-gen sequencing assay developed by WashU Medicine  pathologists. It offers a genomic assessment of solid tumors at initial diagnosis, relapse, and/or metastasis.
Fouad Boulos (@fouad_boulos) 's Twitter Profile Photo

This case was a referral rather than a true consult. The diagnosis was suspicious for invasive carcinoma. Do you agree? I have a definite opinion and diagnosis instead. Let me know what you think and please elaborate :) IHC: CK, p63, and SMM. ER is negative. #breastpath #PathX

This case was a referral rather than a true consult. The diagnosis was suspicious for invasive carcinoma. Do you agree? 

I have a definite opinion and diagnosis instead. Let me know what you think and please elaborate :)

IHC: CK, p63, and SMM. ER is negative.
#breastpath #PathX
Fouad Boulos (@fouad_boulos) 's Twitter Profile Photo

Pitfalls of p63: Case 4 I do not want to say much here. Again, it's H&E low and high magnification, and p63. What is your diagnosis? I will post the answers to today's and tomorrow's cases on Monday to give you all a chance to think about them and share your thoughts. See

Pitfalls of p63: Case 4

I do not want to say much here. Again, it's H&amp;E low and high magnification, and p63.

What is your diagnosis? 

I will post the answers to today's and tomorrow's cases on Monday to give you all a chance to think about them and share your thoughts.

See